Important Safety Information for NAD+

What is NAD+ Therapy?

NAD+ (Nicotinamide Adenine Dinucleotide) is a naturally occurring coenzyme present in every cell of the body. It plays essential roles in cellular energy production, DNA repair, and the activation of proteins involved in longevity and metabolic health. NAD+ levels naturally decline with age, and supplementation aims to restore these levels to support cellular function, energy, and healthy aging.

General Safety Profile

NAD+ therapy is generally well-tolerated by most healthy adults when administered under appropriate medical supervision. Because NAD+ is a naturally occurring molecule in the body, serious adverse effects are uncommon. However, individual responses may vary, and certain precautions apply.

Who Should Not Use NAD+ Therapy?

NAD+ therapy may not be appropriate for individuals who:

• Have a known allergy or hypersensitivity to NAD+ or any component of the formulation
• Have active cancer or a history of cancer (NAD+ may theoretically support cancer cell metabolism; use only with oncologist clearance)
• Have severe liver disease or liver impairment
• Have severe kidney disease or renal failure
• Have uncontrolled high blood pressure
• Have congestive heart failure or significant cardiovascular disease
• Have active systemic infections
• Are pregnant or breastfeeding

Warnings and Precautions

1. Cancer ConsiderationsNAD+ plays a role in cellular energy and repair processes. While no direct causal link between NAD+ supplementation and cancer progression has been established, experts recommend caution in patients with active malignancies or cancer history. Consult with an oncologist before starting NAD+ therapy if you have any cancer history.

2. Cardiovascular ConcernsNAD+ therapy may affect blood pressure and cardiovascular function. Patients with uncontrolled hypertension, heart failure, or other cardiovascular conditions should be evaluated carefully before treatment and monitored during therapy.

3. Metabolic EffectsNAD+ influences glucose metabolism and insulin sensitivity. Patients taking diabetes medications or those with metabolic disorders should be monitored, as blood sugar effects may occur.

4. Liver and Kidney FunctionImpaired liver or kidney function may affect NAD+ metabolism and clearance. Patients with hepatic or renal impairment should use NAD+ with caution and under close medical supervision.

5. Drug InteractionsNAD+ may interact with medications that affect metabolism, blood sugar, or blood pressure. Discuss all medications with your healthcare provider before starting therapy.

6. Infusion-Related Effects (IV Administration)If receiving NAD+ via intravenous infusion, side effects are more likely if the infusion is administered too rapidly. Slow infusion rates significantly reduce the likelihood and severity of side effects.

Common Side Effects

Side effects are typically mild and temporary:

Injection/Infusion-Related:

• Flushing (warmth and redness of the skin)
• Mild nausea
• Headache
• Dizziness or lightheadedness
• Injection site discomfort (redness, swelling, or tenderness)
• Brief chest tightness during infusion

Systemic Effects:

• Fatigue (may occur initially)
• Mild gastrointestinal discomfort
• Temporary muscle cramping
• Sleep changes

Most side effects resolve quickly and can be minimized by:

• Slowing the infusion rate
• Staying well-hydrated
• Fasting for a few hours before treatment (for IV)

Rare but Serious Side Effects

Seek immediate medical attention if you experience:

• Severe allergic reaction (difficulty breathing, throat swelling, severe rash, hives)
• Chest pain or significant heart palpitations
• Severe or persistent headache
• Signs of infection at injection site (increasing redness, warmth, pus, or fever)
• Confusion or significant changes in mental status
• Severe nausea or vomiting that doesn't resolve

Pregnancy and Breastfeeding

Pregnancy: NAD+ therapy is not recommended during pregnancy due to insufficient safety data. If you become pregnant during treatment, discontinue therapy and consult your healthcare provider.

Breastfeeding: It is unknown whether exogenous NAD+ affects breast milk composition or nursing infants. NAD+ therapy is not recommended during breastfeeding.

Drug Interactions

While no major drug-drug interactions have been definitively established, use caution if you take:

• Diabetes medications (insulin, metformin, sulfonylureas): NAD+ may affect blood sugar regulation
• Blood pressure medications: NAD+ may influence blood pressure
• Blood thinners (warfarin, other anticoagulants): Potential for interaction; monitoring may be needed
• Chemotherapy agents: Discuss with oncologist before combining
• Medications affecting mitochondrial function: May have additive or altered effects

Always inform your healthcare provider about all medications, supplements, and herbal products you use.

Administration Guidelines

Subcutaneous Injection:

• Inject under the skin in the abdomen, thigh, or upper arm
• Rotate injection sites to prevent tissue irritation
• Follow your provider's dosing schedule
• Start with lower doses and increase gradually as tolerated

Intravenous Infusion (if applicable):

• Administered by qualified healthcare professionals
• Slow infusion rates (2+ hours) minimize side effects
• Hydrate well before and after treatment
• Consider fasting for several hours before infusion

Storage Instructions

• Store according to manufacturer/pharmacy instructions
• Refrigerate if directed; protect from light
• Do not use after expiration date
• Discard any unused reconstituted solution as directed
• Keep out of reach of children

Monitoring Recommendations

Your healthcare provider may recommend:

• Baseline health evaluation before starting therapy
• Periodic assessment of response and side effects
• Blood tests to monitor metabolic markers, liver function, and kidney function
• Adjustment of dosing based on tolerance and goals

When to Contact Your Healthcare Provider

Contact your provider if you experience:

• Side effects that persist or worsen
• Signs of infection
• Any symptoms that concern you
• Questions about your treatment

Reporting Side Effects

Report adverse effects to the FDA at www.fda.gov/medwatch or by calling 1-800-FDA-1088.

Disclaimer

NAD+ therapy has not been evaluated or approved by the FDA for the prevention or treatment of any disease. This information is for educational purposes only and does not constitute medical advice. Individual results may vary. Consult your healthcare provider with any questions regarding NAD+ therapy.